Person

Frederick H. Waddell

Director, AbbVie

Current S&P 500 boards
2
Current roles
2
Open-market buys
$457K
Open-market sales
$91.4M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Oct 28, 2020IBMBuy1,000$107.50$108K
Nov 1, 2018IBMBuy454$115.98$53K
Nov 1, 2018IBMBuy1,699$115.99$197K
Jan 31, 2018IBMBuy610$163.38$100K
Nov 29, 2017NTRSSale33,080$97.73$3.2M
Nov 29, 2017NTRSSale11,578$98.58$1.1M
Oct 18, 2017NTRSSale36,244$96.10$3.5M
Oct 18, 2017NTRSSale141,720$95.52$13.5M
Sep 27, 2017NTRSSale100,000$92.00$9.2M
May 5, 2017NTRSSale205,923$90.46$18.6M
Nov 15, 2016NTRSSale50,387$82.80$4.2M
Nov 15, 2016NTRSSale79,968$82.16$6.6M
Nov 15, 2016NTRSSale69,645$81.21$5.7M
Nov 9, 2016NTRSSale53,007$75.20$4.0M
Nov 9, 2016NTRSSale100$74.32$7K
Nov 8, 2016NTRSSale38,939$74.13$2.9M
Nov 7, 2016NTRSSale103,214$73.31$7.6M
Nov 3, 2016NTRSSale1,900$73.01$139K
Sep 8, 2016NTRSSale160,367$69.81$11.2M

SEC reporting-owner ID (CIK) 1223690 · all filings on EDGAR